<DOC>
	<DOC>NCT02682849</DOC>
	<brief_summary>The purpose of this study is to evaluate the effectiveness of the PleuraFlow® Active Clearance Technology™ (ACT) System in the management of blood evacuation after cardiac surgery.</brief_summary>
	<brief_title>Active Clearance Technology (ACT) Registry</brief_title>
	<detailed_description />
	<criteria>1. Male or Female subjects 18 years of age or older who received a PleuraFlow System following heart surgery. 2. Patient undergoing cardiac surgery via sternotomy 1. Robotic surgery 2. Any access via thoracotomy 3. Any condition deemed inappropriate for inclusion by the investigators. 4. Intolerance to implantable silicone materials.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>